Narrow Your Results
SBI-101: Stem Cell Therapy in Acute Kidney Injury
We are doing this research to evaluate a new means of treating acute kidney injury (AKI) using
exposure of blood to human mesenchymal stromal cells (hMSCs), sometimes also referred to as
mesenchymal stem cells. AKI is a sudden loss of kidney function, meaning the kidneys cannot
keep up with cleaning your blood of waste substances the way...
The ACCESS Tria Evaluation of Arteriovenous Fistula Outcomes (PRO00003150)
The purpose of this research study is to find out if the experimental drug, sirolimus-eluting collagen implant, is safe and effective in preventing or reducing the narrowing of the fistula where the implant is applied or placed.